Science-driven, results-focused
BIOTECH & CRO

Pikralida is a biotechnology company that combines research and development (R&D) activities with Contract Research Organization (CRO) services.

We focus on clinical-stage projects, developing innovative therapeutic solutions to address unmet medical needs. As a hybrid company, we integrate proprietary R&D efforts in drug development with professional services for pharmaceutical companies, supporting both therapy advancement and innovation in the industry. 

Our mission is to build and maintain an attractive portfolio of projects with the goal of future licensing or sale to pharmaceutical companies for further development and global market introduction. 

Currently, our flagship project is the development of PKL-021, an active inhibitor of matrix metalloproteinases (MMPs). 

More about us
Breakthrough therapies

Breakthrough therapies

Discover Our R&D Projects 

CRO Services

CRO Services

Explore Our Comprehensive CRO Services 

Our Laboratories

mapka Polski z zaznaczonymi lokalizacjami laboratoriów Pikralidy: w Poznaniu i Warszawie

Laboratory in Poznań

Focus Area: Development of pharmaceutical formulations

Laboratory in Warsaw

Focus Area: Development of manufacturing processes for active substances

20 experienced scientists (35% with a PhD)

The Team

Pikralida’s success is driven by an interdisciplinary team of over 20 scientists and experts who combine extensive academic knowledge with practical experience. We successfully execute complex projects, ensuring regulatory compliance and effectively securing funding. Our efforts focus on supporting the development of innovative therapeutic solutions. 

Our team

Pikralida in numbers

Founded
1000
Employees
0
Lab space (m.2)
0
Public funds (mln PLN)
0